Cue Biopharma Vs. Biomarin Pharmaceutical Industry Stock Comparison

Buy

54

CUE
Cue Biopharma

Last Price:

1.51

Seasonality Move:

5.19%

Buy

61

BMRN
Biomarin Pharmaceutical

Last Price:

65.58

Seasonality Move:

13.04%

Buy

54

Cue Biopharma (CUE) is a Buy

Is Cue Biopharma a Buy, Sell or Hold?

The current Cue Biopharma [CUE] share price is $1.50. The Score for CUE is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
CUE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Buy

61

Biomarin Pharmaceutical (BMRN) is a Buy

Is Biomarin Pharmaceutical a Buy, Sell or Hold?

The current Biomarin Pharmaceutical [BMRN] share price is $65.60. The Score for BMRN is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
BMRN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CUE Stock Price Chart

What is Cue Biopharma's stock price today?

The Cue Biopharma share price today is $1.50
The current trend is moderately bearish and CUE is experiencing slight selling pressure.

BMRN Stock Price Chart

What is Biomarin Pharmaceutical's stock price today?

The Biomarin Pharmaceutical share price today is $65.60
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing selling pressure, which indicates risk of future bearish movement.

CUE Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.13	Buy
Relative Strength Index (14 RSI):	50.94	Buy
Chaikin Money Flow:	-441294	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(1.31 - 1.75)	Sell
Bollinger Bands (100):	(0.58 - 1.36)	Buy

BMRN Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-1.6	Sell
Relative Strength Index (14 RSI):	33	Sell
Chaikin Money Flow:	-1236859	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(66.39 - 70.27)	Sell
Bollinger Bands (100):	(69.82 - 87.76)	Sell

CUE Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	1.68	Sell
20-day SMA:	1.62	Sell
50-day SMA:	1.12	Buy
200-day SMA:	1.41	Buy
8-day EMA:	1.62	Sell
20-day EMA:	1.54	Sell
50-day EMA:	1.29	Buy
200-day EMA:	1.47	Buy

BMRN Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	66.37	Sell
20-day SMA:	67.86	Sell
50-day SMA:	71.16	Sell
200-day SMA:	81.82	Sell
8-day EMA:	66.45	Sell
20-day EMA:	67.67	Sell
50-day EMA:	71.58	Sell
200-day EMA:	80.4	Sell

Cue Biopharma Earnings Growth & CUE Earnings Dates

Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.46 per share, and an increase next year of $0.07 per share.

Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates

Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.25 per share, and an increase next year of $0.80 per share.

Cue Biopharma Technical Analysis

	Nov 1	Nov 4	Nov 5	Nov 6	Nov 7	Nov 8	Nov 11	Nov 12	Nov 13	Nov 14
	Nov
	01	04	05	06	07	08	11	12	13	14
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Biomarin Pharmaceutical Technical Analysis

	Nov 1	Nov 4	Nov 5	Nov 6	Nov 7	Nov 8	Nov 11	Nov 12	Nov 13	Nov 14
	Nov
	01	04	05	06	07	08	11	12	13	14
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):